Communication from the Ministry of Health No 529 / 2025 Coll.
Communication from the Ministry of Health on the antigenic composition of vaccines against pneumococcal infections for vaccination of insured persons over 65 years of age
Valid
Communication
Text versions:
12.12.2025
529
COMMUNICATION
Ministry of Health
of 10 December 2025
on the antigenic composition of vaccines against pneumococcal infections for the vaccination of insured persons over 65 years of age
The Ministry of Health pursuant to § 30 (2) (f) of Act No. 48 / 1997 Coll., on Public Health Insurance and amending and supplementing certain related laws, as amended, provides for the antigenic composition of the vaccine against pneumococcal infections for vaccination of insured persons over 65 years of age:
1) conjugate vaccine against pneumococcal infections
One dose (0,5 ml) contains:
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 11,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 31,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 41,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 51,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 6A1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 6B1,2 4,4 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 7F1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 81,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 9V1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 10A1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 11A1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 12F1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 141,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 15B1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 18C1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 19A1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 19F1,2 2,2 micrograms
polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 22F1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 23F1,2 2,2 micrograms
polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 33F1,2 2,2 micrograms
1 Conjugated with CRM197 carrier protein (approximately 51 µg per dose).
2 Adsorbed on aluminium phosphate (0.125 mg aluminium per dose).
OR
2) conjugate vaccine against pneumococcal infections
1 dose (0,5 ml) contains:
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 31 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 6A1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 7F1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 81 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 9N1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 10A1 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 11A1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 12F1 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 15A1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae from deOAc15B (de- O- acetylated serotype 15B) 1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 16F1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 17F1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 19A1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 20A1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 22F1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 23A1 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 23B1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 24F1 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 311 4 μg
Polysaccharide bacterium (pneumococca) Streptococcus pneumoniae serotype 33F1 4 μg
Polysaccharide bacteria (pneumococca) Streptococcus pneumoniae serotype 35B1 4 μg
1Conjugated with protein carrier CRM197. CRM197 is a non-toxic mutant of diphtheric toxin (derived from Corynebacterium diphtheriae C7) recombinant expressed in Pseudomonas fluorescens.
Communication from the Ministry of Health No. 118 / 2024 Coll., on the antigenic composition of vaccines against pneumococcal infections for vaccination of insured persons over 65 years of age, is deleted.
This communication shall take effect on 1 January 2026.
Minister:
Prof. MUDr. Válek, CSc., MBA, EBIR, v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Communication from the Ministry of Health No. 529 / 2025 Coll., on the antigenic composition of vaccines against pneumococcal infections for vaccination of insured persons over 65 years of age |
|---|---|
| Regulation Type | Communication |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 12.12.2025 |
|---|---|
| Effective from | - |
| Effective until | - |
| Status | Valid |
The regulation text is for informational purposes only.
Comments 0